Regulatory Intelligence and the Role of Clinical Studies
What are the challenges in ensuring access to high-cost medicines?
Pharmaceutical Industry – focused on the future
ANVISA – Post-pandemic challenges and perspectives.
Medicine patents in Brazil – legislative changes and their impacts.
Brazilian regulation prices, and future trends
Innovation - The Driving Force of the Pharmaceutical Industry
Unraveling the Abbreviated Development Path
Publication of the Public Consultation for the review of RDC 200 - what is new?
NEW REGULATORY FRAMEWORK OF API
What is the purpose of clinical research on health products?
Incremental innovation: 5 suggestions that can contribute to your success
INCREMENTAL INNOVATION: How to prepare for the changes that will come with the revision of RDC 200
COVID-19: What facilities is ANVISA providing at this time of crisis?
Why are 24% of drug registrations still rejected?
Cannabis: challenges and opportunities
API, BPF and drug dossier - How to align the processes to ensure success in registration?
NEW API REGULATORY FRAMEWORK: Will ANVISA and international manufacturers be prepared?
Publication of the new API regulatory framework: what is essential to know?
